Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVCOM: Aspirin and Ivermectin for COVID-19
NCT04768179Phase 3Unknown
- Sponsor
- Makerere University
- Start
- Feb 2021
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of ivermectin, aspirin in coronavirus disease 2019 (COVID-19), sponsored by Makerere University. Status: unknown.
02
Drugs
ivermectinaspirin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04768179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04768179.